ããæ£è ã§ããåå¦çæ³ä½¿ç¨ããããã¨ããã®ã¯è¸ãç· ãä»ãããããããªæ±ºæãçµæ«æãè¿ããããæ£è ããã«ç·©åçããåå¦çæ³ã¯æ¯ã¨è¨ãããï¼ãã®çåã«çããç 究ã 2002å¹´ãã2008å¹´ç»é²ã®çµæ«æçæ£è ã®å¤æ½è¨ã»é·è»¸ã³ãã¼ãããåå¦çæ³ä½¿ç¨ã¨æ£è ããã©ã¼ãã³ã¹ç¶æ ã®æ©è½è©ä¾¡ï¼QOL near death (QOD) ç 究ã§ãããã©ã¼ãã³ã¹ãä¿ããã¦ããç¶æ³ã«ããã¦ããçµæ«æãããããæ£è ãããã¡ã«ãããåå¦çæ³ä½¿ç¨ã¯QOLãæªåããããããã¦ãããã©ã¼ãã³ã¹ãæªãç¶æ³ã®æ¹ã ã§ããæ¹åãããªãã¨ããäºå®ã Chemotherapy Use, Performance Status, and Quality of Life at the End of Life Holly G. Prigerson, et. al. JAMA Oncol. Published online July 23, 20
{{#tags}}- {{label}}
{{/tags}}